Files
Abstract
This paper examines the impact of European Union policy on genetically modified organisms on trade flows and economic growth. Restrictive European Union policies on biotech production and consumption result in: an effective export subsidy of capital to the South; new trade flows; North America being the dominant producer of biotech research and development; the South being a dominant producer of biotech products; and the European Union being the dominant producer of traditional agricultural products.